Climb Bio Inc (CLYM)
Healthcare
Biotechnology
11.90 $
-1.5%
vs. previous close
Closing price · As of: 31. Jul 2026
Climb Bio Inc (CLYM) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -54 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -5.0 | -14 | -36 | -37 | -21 | -16 | -54 | |
| – | – | – | – | – | 0.0 | 0.1 | |
| – | 0.7 | 3.7 | 7.0 | 13 | 5.6 | 8.1 | |
| -0.3 | -2.9 | -4.2 | 0.2 | 3.8 | 1.7 | -0.6 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| – | 8.1 | -115 | 34 | 69 | -121 | 2.8 | |
| 26 | 4.9 | 177 | 0.0 | 0.8 | 131 | 0.0 | |
| 21 | -0.7 | 26 | -3.3 | 50 | -5.9 | -52 | |
| -5.0 | -14 | -36 | -37 | -21 | -16 | -55 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.